S. David Kimball

Who is S. David Kimball?

Dr. Kimball has 25 years experience in the discovery and development

of small molecule drug candidates. He was most recently Vice President,

Medicinal Chemistry at Lexicon Pharmaceuticals in Princeton, NJ,

beginning in 2001. While at Lexicon, Dr. Kimball was responsible for

building an organization of over 75 chemists, including medicinal,

analytical, computational, process research and development, library

synthesis and outsourcing chemistry. Lexicon Pharmaceuticals’ small

molecule pipeline was derived from applying this chemistry capability

to the novel drug targets discovered by its genetics platform.

Dr. Kimball spent the 19 years prior to Lexicon at Bristol-Myers

Squibb Pharmaceutical Research Institute, most recently as Research

Fellow in the Division of Medicinal Chemistry, Princeton, NJ. During

his tenure at BMS, he led several significant drug discovery and

development research efforts that culminated in clinical compounds.

Dr. Kimball has lectured widely on drug discovery and has been an

Associate Member of the Graduate Faculty at Rutgers University School

of Pharmacy since 1989. He holds a Ph.D. in Organic Chemistry/Chemical

Biology from the State University of New York at Stony Brook. Dr.

Kimball joined Pharmacopeia in September of 2007.